Salmonella enterica serovar Paratyphi: Difference between revisions
No edit summary |
|||
| (49 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
{{Conway}} | |||
{{ | |||
[[File:Salmonella paratyphi B.PNG|400px|thumb|right|Image of <i>Salmonella</i> Paratyphi. From: Food Poison Journal [http://www.foodpoisonjournal.com/foodborne-illness-outbreaks/salmonella-paratyphi-b-north-carolina-link-to-tennessee-new-york-and-south-carolina/#.U8WuDxZn7cY]]] | [[File:Salmonella paratyphi B.PNG|400px|thumb|right|Image of <i>Salmonella</i> Paratyphi. From: Food Poison Journal [http://www.foodpoisonjournal.com/foodborne-illness-outbreaks/salmonella-paratyphi-b-north-carolina-link-to-tennessee-new-york-and-south-carolina/#.U8WuDxZn7cY]]] | ||
==Etiology/Bacteriology== | ==Etiology/Bacteriology== | ||
| Line 7: | Line 5: | ||
| Domain = [[Bacteria]] | | Domain = [[Bacteria]] | ||
| Phylum = [[Proteobacteria]] | | Phylum = [[Proteobacteria]] | ||
| Class = | | Class = Gammaproteobacteria | ||
| Order = [[Enterobacteriales]] | | Order = [[Enterobacteriales]] | ||
| Family = | | Family = Enterobacteriaceae | ||
| Genus = [[Salmonella]] | | Genus = [[Salmonella]] | ||
| species = [[S. enterica]] | | species = [[S. enterica]] | ||
| Line 16: | Line 14: | ||
===Description=== | ===Description=== | ||
<i>Salmonella enterica </i> are motile, non-lactose fermenting, non-spore forming, | <i>Salmonella enterica </i> are motile, non-lactose fermenting, non-spore forming, gram-negative, rod-shaped bacterium. <i>Salmonella enterica </i> have the ability to ferment glucose resulting in the production of acid and gas [[#References|[1]]] . Within the subspecies, <i>enterica</i>, there are three serotypes; Paratyphi A, B, and C. These serotypes are human pathogens that cause paratyphoid fever. Paratyphis A and B are responsible for more cases of disease than infection from Paratyphi C. In the United States, paratyphoid fever is relatively uncommon, while, an estimated 5.4 million outbreaks occurred in East Asia in 2000. <i>Salmonella enterica </i> serovar Paratyphi, also referred to as <i>Salmonella</i> Paratyphi, causes 3% of invasive <i>Salmonella</i> infections in the U.S and is correlated to poor sanitation and lack of clean drinking water. Prevention entails basic sanitation and education [[#References|[2]]]. Symptoms of paratyphoid fever typically include fever peaking around 40°C/, red rash covering the trunk, constipation, severe stomach pain, and loss of appetite. Diagnosing paratyphoid fever is difficult for many health care providers. Although the disease can sometimes be detected through a simple blood culture, a more accurate examination for the disease can be found by a bone marrow culture. Paratyphoid fever and typhoid fever are clinically indistinguishable, thus treatment of the paratyphoid fever is similar to the treatment of typhoid fever. Specific antibiotics can shorten the course of the fever and reduce the chances of death. Paratyphi A infections lead to complications in 10-15% of cases, such as meningitis, endocarditis, hepatic absess, gall bladder cancer, and pancytopenia [[#References|[2]]]. Upon infection by <i>Salmonella</i> Paratyphi, the immune system mounts a humoral response predominately producing and utilizing IgA antibodies. Research indicates that a cell-mediated response is also employed. | ||
There are currently no vaccines to prevent <i>Salmonella</i> Paratyphi ; however, studies are being conducted concerning the efficacy of the <i>Salmonella</i> Typhi Ty21a-vaccine providing protection from <i>Salmonella</i> Paratyphi as well. | There are currently no vaccines to prevent <i>Salmonella</i> Paratyphi ; however, studies are being conducted concerning the efficacy of the <i>Salmonella</i> Typhi Ty21a-vaccine providing protection from <i>Salmonella</i> Paratyphi as well. | ||
==Pathogenesis== | ==Pathogenesis== | ||
The pathogenesis mechanisms of <i>Salmonella | The pathogenesis mechanisms of <i>Salmonella</i> Paratyphi bacterium are not completely understood, but there are several key features of the bacterium's ability to infect and colonize a human host. The bacterium is able to survive the low pH of the stomach and enter the intestines. The mechanism which <i>Salmonella</i> Paratyphi uses to adhere to the epithelial cells of the intestines are unknown. Paratyphi B specifically utilizes mechanisms which enable it to cross the intestinal walls and survive in host tissue. A high affinity for iron-uptake utilizing siderophores may also be important regarding the pathogenicity of this particular bacterium [[#References|[3]]]. | ||
<br> | <br><br> | ||
<i>Salmonella</i> Paratyphi initially colonizes the human gastrointestinal tract, causing enteritis, which may or may not result in diarrhea. The bacteria then pass through the mucosa layer and invade the lymphoid tissues and macrophages. If left untreated, <i>Salmonella</i> Paratyphi begin to divide within these cells and are taken to the lymph nodes. A systemic infection develops 8-14 days after infection and the bacteria can now be found in the liver, spleen and bone marrow [[#References|[19]]]. | |||
===Transmission=== | ===Transmission=== | ||
<i>Salmonella enterica</i> serovars Paratyphi is transmitted primarily through humans, although there are rare cases of transmission from domesticated animals. The pathogen is most frequently encountered through the ingestion of water, contaminated with feces from an infected individual or an asymptomatic carrier of the disease. Milk, raw vegetables, salads, shellfish, and ice can also transmit the pathogen if not properly washed or prepared. Also, there are rare reports of the disease being transmitted sexually | <i>Salmonella enterica</i> serovars Paratyphi is transmitted primarily through humans, although there are rare cases of transmission from domesticated animals. The pathogen is most frequently encountered through the ingestion of water, contaminated with feces from an infected individual or an asymptomatic carrier of the disease. Milk, raw vegetables, salads, shellfish, and ice can also transmit the pathogen if not properly washed or prepared. Also, there are rare reports of the disease being transmitted sexually [[#References|[4]]]. | ||
===Infectious dose, incubation, and colonization=== | ===Infectious dose, incubation, and colonization=== | ||
The infectious dose of <i>Salmonella</i> Paratyphi is generally greater than 1000 organisms. The incubation period of gastroenteritis caused by <i>Salmonella</i> Paratyphi is between one and ten days, however, the incubation period for enteric fever caused by <i>Salmonella</i> Paratyphi is longer, lasting between one and three weeks. <i>Salmonella</i> Paratyphi colonize the intestines, but this can be buffered by stomach acidity. This defense necessitates a greater number of bacteria to be ingested in order to result in symptomatic infection | The infectious dose of <i>Salmonella</i> Paratyphi is generally greater than 1000 organisms. The incubation period of gastroenteritis caused by <i>Salmonella</i> Paratyphi is between one and ten days, however, the incubation period for enteric fever caused by <i>Salmonella</i> Paratyphi is longer, lasting between one and three weeks. <i>Salmonella</i> Paratyphi colonize the intestines, but this can be buffered by stomach acidity. This defense necessitates a greater number of bacteria to be ingested in order to result in symptomatic infection [[#References|[5]]]. | ||
===Epidemiology=== | ===Epidemiology=== | ||
Paratyphoid fever generally occurs sporadically or in contained outbreaks. Approximately six million cases of Paratyphoid fever are reported annually throughout the world. In the United States approximately one hundred cases are reported, with most occurring in recent travelers. The risk of Paratyphi A is most preeminent in South and Southeast Asia. Southern Asia presents the highest risk of contracting nalixidic acid resistant paratyphoid fever, as well as multidrug resistant paratyphoid fever. Antibiotic resistant strains of paratyphoid fever are resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole | Paratyphoid fever generally occurs sporadically or in contained outbreaks. Approximately six million cases of Paratyphoid fever are reported annually throughout the world. In the United States approximately one hundred cases are reported, with most occurring in recent travelers. The risk of Paratyphi A is most preeminent in South and Southeast Asia. Southern Asia presents the highest risk of contracting nalixidic acid resistant paratyphoid fever, as well as multidrug resistant paratyphoid fever. Antibiotic resistant strains of paratyphoid fever are resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole [[#References|[4]]] [[#References|[5]]]. Since the start of the millennium, cases of <i>Salmonella enterica </i> serovar Paratyphi, also referred to as <i>Salmonella</i> Paratyphi, have steadly increased [[#References|[16]]] [[#References|[18]]]. In many areas <i>S.</i> Paratyphi A is now the leading cause of entric fever. | ||
===Virulence factors=== | ===Virulence factors=== | ||
The virulence factors of <i>Salmonella | The virulence factors of <i>Salmonella</i> Paratyphi are predominantly the same as those of other <i>Salmonella enterica</i> serotypes. Two of the major virulence factors include the <i>Salmonella</i> pathogenicity Islands I and II. SPI1 encodes genes which contain a type III secretion system. This system allows the pathogen to inject effector proteins directly into the host cell's cytoplasm, and aids in the bacterial invasion of epithelial cells. SPI2 has roles in bacterial replication while within a <i>Salmonella</i>-containing vacuole. SPI2 also encodes for a type III secretion system [[#References|[6]]] [[#References|[7]]]. | ||
<br><br> | <br><br> | ||
Another important virulence factor is found particularly in Paratyphi A. Cytolysin A (ClyA) is a cytotoxic protein which forms pores in membranes. It is a virulence factor most commonly attributed to <i>Escherichia coli</i>, but the gene has been found to be conserved in many <i>Salmonella enterica</i> species | Another important virulence factor is found particularly in Paratyphi A. Cytolysin A (ClyA) is a cytotoxic protein which forms pores in membranes. It is a virulence factor most commonly attributed to <i>Escherichia coli</i>, but the gene has been found to be conserved in many <i>Salmonella enterica</i> species [[#References|[8]]]. | ||
<br><br> | <br><br> | ||
Several studies have been done to investigate different plasmids present in <i>Salmonella enterica</i> serotypes. Their role in virulence is not well understood, but studies have shown that Paratyphi C contains a large cryptic plasmid, which is thought to play some role in the virulence of the strain. [[#References|[ | Several studies have been done to investigate different plasmids present in <i>Salmonella enterica</i> serotypes. Their role in virulence is not well understood, but studies have shown that Paratyphi C contains a large cryptic plasmid, which is thought to play some role in the virulence of the strain [[#References|[6]]]. | ||
<br><br> | |||
It has recently been shown that a fully functional flagellum is required for <i>S.</i> Paratyphi to invade host epithelial cells [[#References|[17]]]. | |||
==Clinical features== | ==Clinical features== | ||
[[Image:paratyphoid_fever.jpg|thumb|270px|left|Red spots on body; characteristic of paratyphoid fever[http://medical-enc.com/paratyphoid_fever.html/]]] | |||
===Symptoms=== | ===Symptoms=== | ||
Paratyphoid fever is very similar to typhoid fever | Paratyphoid fever is very similar to typhoid fever. Both fevers are often mistaken for one another. However, symptoms of paratyphoid fever have been known to be less severe because the infection is not nearly as extreme as typhoid fever [[#References|[18]]]. Symptoms from paratyphoid fever usually occur between 6-30 days after being infected. The most common, and perhaps prominent, symptom is severe fatigue accompanied by a fever. The fever typically presents as low-grade and can rise as high as 40°C by the third and fourth days of the illness. Additional symptoms that commonly appear include a headache, a distinct red rash over the trunk, cough, stomach pain, loss of appetite, and constipation or severe diarrhea [[#References|[9]]] [[#References|[10]]] [[#References|[11]]]. | ||
<br><br> | |||
===Morbidity/Mortality=== | ===Morbidity/Mortality=== | ||
Once treated, approximately 10% of those with paratyphoid fever will continue to secrete S. paratyphi in their stool for up to three months, which could then be passed on to infect others. Around 2-3% of the recovering patients become permanent carriers for the disease [[#References|[10]]]. Paratyphoid fever was once a major cause of mortality throughout the world; however, | Once treated, approximately 10% of those with paratyphoid fever will continue to secrete S. paratyphi in their stool for up to three months, which could then be passed on to infect others. Around 2-3% of the recovering patients become permanent carriers for the disease [[#References|[10]]]. Paratyphoid fever was once a major cause of mortality throughout the world; however, various prevention mechanisms have begun to eradicate the chance for infection . Nevertheless, the disease is still a problem in tropical and underdeveloped countries of the world, typically Africa, Latin America, and Southeast Asia. Although the findings are some what inconclusive, it is believed that approximately 5.4 million cases of paratyphoid fever occur every year [[#References|[12]]]. | ||
<br><br> | |||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of paratyphoid fever can be confirmed by a culture of the blood or bone marrow. As the disease progresses, blood bacterial counts decline which make the blood cultures positive in only about 40-60% of cases. The validity of the test can be increased to 80% if multiple sets of blood cultures are taken. The most accurate way to test for paratyphoid fever is by a bone marrow culture because bacterial counts are typically ten times higher in the bone marrow than in a blood culture. An additional test to diagnose the disease is to perform a biopsy on the rose-colored rash on the trunk of the patient | The diagnosis of paratyphoid fever can be confirmed by a culture of the blood or bone marrow. As the disease progresses, blood bacterial counts decline which make the blood cultures positive in only about 40-60% of cases. The validity of the test can be increased to 80% if multiple sets of blood cultures are taken. The most accurate way to test for paratyphoid fever is by a bone marrow culture because bacterial counts are typically ten times higher in the bone marrow than in a blood culture. An additional test to diagnose the disease is to perform a biopsy on the rose-colored rash on the trunk of the patient [[#References|[10]]]. | ||
==Treatment== | ==Treatment== | ||
Paratyphoid fever is treated with specific antibiotics to shorten the course of paratyphoid fever and decrease the chance of death. In most parts of the world ciprofloxacin, a fluoroquinolone, is used to combat the disease. In Indian countries | Paratyphoid fever is treated with specific antibiotics to shorten the course of paratyphoid fever and to decrease the chance of death. In most parts of the world ciprofloxacin, a fluoroquinolone, is used to combat the disease. In Indian countries, cases of Paratyphoid fever are more prevalent. In these countries, health officials use cephalosporins for treatment due to increased resistance towards fluoroquinolones and nalidixic acid. Azithromycin has become more commonly used due to the increase of multi-drug resistant strains. After treatment, three to five days may be required for the antibiotic to resolve the fever completely. Some patients may feel worse during the several days of waiting for the fever to end, however, the height of the fever decreases each day. If the fever is not resolved within five days, alternative antibiotics should be considered [[#References|[13]]]. | ||
==Prevention== | ==Prevention== | ||
===Risk Avoidance=== | ===Risk Avoidance=== | ||
The incidence of enteric fever is most strongly correlated with poor sanitation and lack of clean drinking water. This is because <i>Salmonella</i> Paratyphi is transmitted through consumption of contaminated food or water. In order to decrease the incidence of this disease it is important to avoid the consumption of contaminated food or water, provide education about food and water safety, and promote basic sanitation | The incidence of enteric fever is most strongly correlated with poor sanitation and lack of clean drinking water. This is because <i>Salmonella</i> Paratyphi is transmitted through consumption of contaminated food or water. In order to decrease the incidence of this disease it is important to avoid the consumption of contaminated food or water, provide education about food and water safety, and promote basic sanitation [[#References|[14]]] [[#References|[12]]]. | ||
===Immunization=== | ===Immunization=== | ||
There are currently no vaccines clinically used to defend against <i>Salmonella</i> Paratyphi [[#References|[12]]] . Recent studies have indicated that this organism displays evidence drug resistance. For example, it was discovered that <i>Salmonella</i> Paratyphi has limited sensitivity of ofloxacin, nalidixic acid, and ciprofloxacin | There are currently no vaccines clinically used to defend against <i>Salmonella</i> Paratyphi [[#References|[12]]]. Recent studies have indicated that this organism displays evidence drug resistance. For example, it was discovered that <i>Salmonella</i> Paratyphi has limited sensitivity of ofloxacin, nalidixic acid, and ciprofloxacin [[#References|[14]]]. | ||
Because of the evidence for drug resistance, <i>Salmonella</i> Paratyphi poses a potential health risk and there is a growing necessity for the development of an effective vaccine. There have been studies on the potential use of an oral vaccine that would be used to prevent <i> Salmonella </i> Paratyphi infections, as well as avert typhoid fever. The oral live <i> Salmonella </i> Typhi Ty21a-vaccine has been shown to offer some protection against <i>Salmonella</i> Paratyphi B, slightly less protection against <i>Salmonella</i> Paratyphi A, and no protection against <i>Salmonella</i> Paratyphi C | Because of the evidence for drug resistance, <i>Salmonella</i> Paratyphi poses a potential health risk and there is a growing necessity for the development of an effective vaccine. There have been studies on the potential use of an oral vaccine that would be used to prevent <i> Salmonella </i> Paratyphi infections, as well as avert typhoid fever. The oral live <i> Salmonella </i> Typhi Ty21a-vaccine has been shown to offer some protection against <i>Salmonella</i> Paratyphi B, slightly less protection against <i>Salmonella</i> Paratyphi A, and no protection against <i>Salmonella</i> Paratyphi C [[#References|[12]]]. These varying levels of prevention are due to differences in the shared epitopes of each strain. Despite the research that has been done, there are still no vaccines currently being used in a clinical setting. | ||
==Host Immune Response== | ==Host Immune Response== | ||
When the body is infected by <i>Salmonella</i> Paratyphi, a humoral immune response is mounted. The response primarily takes place in the intestinal tract, since the gut is the first line of defense against enteric diseases [[#References|[15]]]. Based on research performed | When the body is infected by <i>Salmonella</i> Paratyphi, a humoral immune response is mounted. The response primarily takes place in the intestinal tract, since the gut is the first line of defense against enteric diseases [[#References|[15]]]. Based on research performed using the Ty21a-vaccine, after the host was exposed to the oral vaccine there was a predominance of IgA antibodies. As part of the immune response, it is believed that after the B cells arrive in the intestinal lining, they undergo isotype switching from IgM to IgA. This specific immunoglobulin isotype is produced to stimulate the destruction of <i>Salmonella</i> bacteria. Other research indicates that a cell-mediated response is also activated upon infection [[#References|[12]]]. In a 2011 study of a paratyphi outbreak in Napal, researchers found that infected patients had elevated levels of several cytokines, including interferon gamma, tumor necrosis factor alpha (TNF-α), IL-6, IL-8, IL-10, and IL-15. Interestingly, IL-12 was not elevated in patients, but is elevated in patients suffering from nontyphoidal <i>Salmonella</i> infections [[#References|[19]]]. | ||
==References== | ==References== | ||
| Line 84: | Line 89: | ||
14 Maskey AP, et al: <i>Salmonella enterica</i> Serovar Paratyphi A and S. <i>enterica</i> Serovar Typhi Cause Indistinguishable Clinical Syndromes
in Kathmandu, Nepal. <i>Clinical Infectious Diseases</i> 2006, 42: 1247-53.<br> | 14 Maskey AP, et al: <i>Salmonella enterica</i> Serovar Paratyphi A and S. <i>enterica</i> Serovar Typhi Cause Indistinguishable Clinical Syndromes
in Kathmandu, Nepal. <i>Clinical Infectious Diseases</i> 2006, 42: 1247-53.<br> | ||
15 Rezwanul W, et al: Live Oral Typhoid Vaccine Ty21a Induces Cross-Reactive Humoral Immune Responses against <i>Salmonella enterica</i> Serovar Paratyphi A and S. Paratyphi B in Humans. <i>Clinical and Vaccine Immunology</i> 2012, 19(6): 825-834.<br> | 15 Rezwanul W, et al: Live Oral Typhoid Vaccine Ty21a Induces Cross-Reactive Humoral Immune Responses against <i>Salmonella enterica</i> Serovar Paratyphi A and S. Paratyphi B in Humans. <i>Clinical and Vaccine Immunology</i> 2012, 19(6): 825-834.<br> | ||
16 Baker, S, Karkey, A, Parry, C. Are we adequately prepared for the emergence of <i>Salmonella enterica</i> serovar Paratyphi A?. <i>The Lancet Global Health</i>. http://dx.doi.org/10.1016/S2214-109X(14)70009-9.<br> | |||
17 Elhadad, D., et al. Flagellin is required for host cell invasion and normal SPI-1 expression by Salmonella Paratyphi A. <i>Infection and Immunity</i>. 10.1128/IAI.00468-15. http://www.ncbi.nlm.nih.gov/pubmed/26056383.<br> | |||
18 Teh, C, Chua, K, Thong, K. Paratyphoid Fever: Splicing the Global Analyses. <i>Int J Med Sci</i>. 10.7150/ijms.7768. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045793/. <br> | |||
19 Gal-Mor O, et al: Molecular and Cellular Characterization of a Salmonella enterica Serovar Paratyphi A Outbreak Strain and the Human Immune Response to Infection. <i>Clin Vaccine Immunol</i>. 10.1128/CVI.05468-11. http://cvi.asm.org/content/19/2/146.full. <br> | |||
Created by MaKenzi Burke, Madeline Gabe, Regina Swenton, and Jordan Voth, students of Tyrrell Conway at the University of Oklahoma. | Created by MaKenzi Burke, Madeline Gabe, Regina Swenton, and Jordan Voth, students of Tyrrell Conway at the University of Oklahoma. | ||
<br><br> | |||
Edited by William Mangin and Tyler Potter, students of Tyrrell Conway at the University of Oklahoma. | |||
Latest revision as of 16:39, 11 February 2016
Etiology/Bacteriology
Taxonomy
| Domain = Bacteria
| Phylum = Proteobacteria
| Class = Gammaproteobacteria
| Order = Enterobacteriales
| Family = Enterobacteriaceae
| Genus = Salmonella
| species = S. enterica
| subspecies = enterica, serovar Paratyphi A, B, and C
{|NCBI: Taxonomy Genome: Genome|}
Description
Salmonella enterica are motile, non-lactose fermenting, non-spore forming, gram-negative, rod-shaped bacterium. Salmonella enterica have the ability to ferment glucose resulting in the production of acid and gas [1] . Within the subspecies, enterica, there are three serotypes; Paratyphi A, B, and C. These serotypes are human pathogens that cause paratyphoid fever. Paratyphis A and B are responsible for more cases of disease than infection from Paratyphi C. In the United States, paratyphoid fever is relatively uncommon, while, an estimated 5.4 million outbreaks occurred in East Asia in 2000. Salmonella enterica serovar Paratyphi, also referred to as Salmonella Paratyphi, causes 3% of invasive Salmonella infections in the U.S and is correlated to poor sanitation and lack of clean drinking water. Prevention entails basic sanitation and education [2]. Symptoms of paratyphoid fever typically include fever peaking around 40°C/, red rash covering the trunk, constipation, severe stomach pain, and loss of appetite. Diagnosing paratyphoid fever is difficult for many health care providers. Although the disease can sometimes be detected through a simple blood culture, a more accurate examination for the disease can be found by a bone marrow culture. Paratyphoid fever and typhoid fever are clinically indistinguishable, thus treatment of the paratyphoid fever is similar to the treatment of typhoid fever. Specific antibiotics can shorten the course of the fever and reduce the chances of death. Paratyphi A infections lead to complications in 10-15% of cases, such as meningitis, endocarditis, hepatic absess, gall bladder cancer, and pancytopenia [2]. Upon infection by Salmonella Paratyphi, the immune system mounts a humoral response predominately producing and utilizing IgA antibodies. Research indicates that a cell-mediated response is also employed. There are currently no vaccines to prevent Salmonella Paratyphi ; however, studies are being conducted concerning the efficacy of the Salmonella Typhi Ty21a-vaccine providing protection from Salmonella Paratyphi as well.
Pathogenesis
The pathogenesis mechanisms of Salmonella Paratyphi bacterium are not completely understood, but there are several key features of the bacterium's ability to infect and colonize a human host. The bacterium is able to survive the low pH of the stomach and enter the intestines. The mechanism which Salmonella Paratyphi uses to adhere to the epithelial cells of the intestines are unknown. Paratyphi B specifically utilizes mechanisms which enable it to cross the intestinal walls and survive in host tissue. A high affinity for iron-uptake utilizing siderophores may also be important regarding the pathogenicity of this particular bacterium [3].
Salmonella Paratyphi initially colonizes the human gastrointestinal tract, causing enteritis, which may or may not result in diarrhea. The bacteria then pass through the mucosa layer and invade the lymphoid tissues and macrophages. If left untreated, Salmonella Paratyphi begin to divide within these cells and are taken to the lymph nodes. A systemic infection develops 8-14 days after infection and the bacteria can now be found in the liver, spleen and bone marrow [19].
Transmission
Salmonella enterica serovars Paratyphi is transmitted primarily through humans, although there are rare cases of transmission from domesticated animals. The pathogen is most frequently encountered through the ingestion of water, contaminated with feces from an infected individual or an asymptomatic carrier of the disease. Milk, raw vegetables, salads, shellfish, and ice can also transmit the pathogen if not properly washed or prepared. Also, there are rare reports of the disease being transmitted sexually [4].
Infectious dose, incubation, and colonization
The infectious dose of Salmonella Paratyphi is generally greater than 1000 organisms. The incubation period of gastroenteritis caused by Salmonella Paratyphi is between one and ten days, however, the incubation period for enteric fever caused by Salmonella Paratyphi is longer, lasting between one and three weeks. Salmonella Paratyphi colonize the intestines, but this can be buffered by stomach acidity. This defense necessitates a greater number of bacteria to be ingested in order to result in symptomatic infection [5].
Epidemiology
Paratyphoid fever generally occurs sporadically or in contained outbreaks. Approximately six million cases of Paratyphoid fever are reported annually throughout the world. In the United States approximately one hundred cases are reported, with most occurring in recent travelers. The risk of Paratyphi A is most preeminent in South and Southeast Asia. Southern Asia presents the highest risk of contracting nalixidic acid resistant paratyphoid fever, as well as multidrug resistant paratyphoid fever. Antibiotic resistant strains of paratyphoid fever are resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole [4] [5]. Since the start of the millennium, cases of Salmonella enterica serovar Paratyphi, also referred to as Salmonella Paratyphi, have steadly increased [16] [18]. In many areas S. Paratyphi A is now the leading cause of entric fever.
Virulence factors
The virulence factors of Salmonella Paratyphi are predominantly the same as those of other Salmonella enterica serotypes. Two of the major virulence factors include the Salmonella pathogenicity Islands I and II. SPI1 encodes genes which contain a type III secretion system. This system allows the pathogen to inject effector proteins directly into the host cell's cytoplasm, and aids in the bacterial invasion of epithelial cells. SPI2 has roles in bacterial replication while within a Salmonella-containing vacuole. SPI2 also encodes for a type III secretion system [6] [7].
Another important virulence factor is found particularly in Paratyphi A. Cytolysin A (ClyA) is a cytotoxic protein which forms pores in membranes. It is a virulence factor most commonly attributed to Escherichia coli, but the gene has been found to be conserved in many Salmonella enterica species [8].
Several studies have been done to investigate different plasmids present in Salmonella enterica serotypes. Their role in virulence is not well understood, but studies have shown that Paratyphi C contains a large cryptic plasmid, which is thought to play some role in the virulence of the strain [6].
It has recently been shown that a fully functional flagellum is required for S. Paratyphi to invade host epithelial cells [17].
Clinical features
Symptoms
Paratyphoid fever is very similar to typhoid fever. Both fevers are often mistaken for one another. However, symptoms of paratyphoid fever have been known to be less severe because the infection is not nearly as extreme as typhoid fever [18]. Symptoms from paratyphoid fever usually occur between 6-30 days after being infected. The most common, and perhaps prominent, symptom is severe fatigue accompanied by a fever. The fever typically presents as low-grade and can rise as high as 40°C by the third and fourth days of the illness. Additional symptoms that commonly appear include a headache, a distinct red rash over the trunk, cough, stomach pain, loss of appetite, and constipation or severe diarrhea [9] [10] [11].
Morbidity/Mortality
Once treated, approximately 10% of those with paratyphoid fever will continue to secrete S. paratyphi in their stool for up to three months, which could then be passed on to infect others. Around 2-3% of the recovering patients become permanent carriers for the disease [10]. Paratyphoid fever was once a major cause of mortality throughout the world; however, various prevention mechanisms have begun to eradicate the chance for infection . Nevertheless, the disease is still a problem in tropical and underdeveloped countries of the world, typically Africa, Latin America, and Southeast Asia. Although the findings are some what inconclusive, it is believed that approximately 5.4 million cases of paratyphoid fever occur every year [12].
Diagnosis
The diagnosis of paratyphoid fever can be confirmed by a culture of the blood or bone marrow. As the disease progresses, blood bacterial counts decline which make the blood cultures positive in only about 40-60% of cases. The validity of the test can be increased to 80% if multiple sets of blood cultures are taken. The most accurate way to test for paratyphoid fever is by a bone marrow culture because bacterial counts are typically ten times higher in the bone marrow than in a blood culture. An additional test to diagnose the disease is to perform a biopsy on the rose-colored rash on the trunk of the patient [10].
Treatment
Paratyphoid fever is treated with specific antibiotics to shorten the course of paratyphoid fever and to decrease the chance of death. In most parts of the world ciprofloxacin, a fluoroquinolone, is used to combat the disease. In Indian countries, cases of Paratyphoid fever are more prevalent. In these countries, health officials use cephalosporins for treatment due to increased resistance towards fluoroquinolones and nalidixic acid. Azithromycin has become more commonly used due to the increase of multi-drug resistant strains. After treatment, three to five days may be required for the antibiotic to resolve the fever completely. Some patients may feel worse during the several days of waiting for the fever to end, however, the height of the fever decreases each day. If the fever is not resolved within five days, alternative antibiotics should be considered [13].
Prevention
Risk Avoidance
The incidence of enteric fever is most strongly correlated with poor sanitation and lack of clean drinking water. This is because Salmonella Paratyphi is transmitted through consumption of contaminated food or water. In order to decrease the incidence of this disease it is important to avoid the consumption of contaminated food or water, provide education about food and water safety, and promote basic sanitation [14] [12].
Immunization
There are currently no vaccines clinically used to defend against Salmonella Paratyphi [12]. Recent studies have indicated that this organism displays evidence drug resistance. For example, it was discovered that Salmonella Paratyphi has limited sensitivity of ofloxacin, nalidixic acid, and ciprofloxacin [14].
Because of the evidence for drug resistance, Salmonella Paratyphi poses a potential health risk and there is a growing necessity for the development of an effective vaccine. There have been studies on the potential use of an oral vaccine that would be used to prevent Salmonella Paratyphi infections, as well as avert typhoid fever. The oral live Salmonella Typhi Ty21a-vaccine has been shown to offer some protection against Salmonella Paratyphi B, slightly less protection against Salmonella Paratyphi A, and no protection against Salmonella Paratyphi C [12]. These varying levels of prevention are due to differences in the shared epitopes of each strain. Despite the research that has been done, there are still no vaccines currently being used in a clinical setting.
Host Immune Response
When the body is infected by Salmonella Paratyphi, a humoral immune response is mounted. The response primarily takes place in the intestinal tract, since the gut is the first line of defense against enteric diseases [15]. Based on research performed using the Ty21a-vaccine, after the host was exposed to the oral vaccine there was a predominance of IgA antibodies. As part of the immune response, it is believed that after the B cells arrive in the intestinal lining, they undergo isotype switching from IgM to IgA. This specific immunoglobulin isotype is produced to stimulate the destruction of Salmonella bacteria. Other research indicates that a cell-mediated response is also activated upon infection [12]. In a 2011 study of a paratyphi outbreak in Napal, researchers found that infected patients had elevated levels of several cytokines, including interferon gamma, tumor necrosis factor alpha (TNF-α), IL-6, IL-8, IL-10, and IL-15. Interestingly, IL-12 was not elevated in patients, but is elevated in patients suffering from nontyphoidal Salmonella infections [19].
References
1 E. Umeh, C. Agbulu. Distribution Pattern Of Salmonella Typhoidal Serotypes In Benue State Central, Nigeria. The Internet Journal of Epidemiology
http://ispub.com/IJE/8/1/5749
2 Sundeep K. Gupta, et al. Laboratory-Based Surveillance of Paratyphoid Fever in the United States: Travel and Antimicrobial Resistance. Clinical Infectious Diseases. 46(11):1656-1663 http://cid.oxfordjournals.org/content/46/11/1656.full
3 Chart, H. The pathogenicity of strains of Salmonella paratyphi B and Salmonella java. Journal of Applied Microbiology. 94:340-348. http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2672.2003.01863.x/pdf
4 Public Health Agency of Canada (PHAC). Salmonella Paratyphi. Infectious Disease Index. http://www.msdsonline.com/resources/msds-resources/free-safety-data-sheet-index/salmonella-paratyphi.aspx
5 Center for Disease Control and Prevention (CDC). Typhoid and Paratyphoid Fever. Traveler’s Health. http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/typhoid-and-paratyphoid-fever
6 Ibarra, J Antonio and Steele-Mortimer, Olivia. Salmonella – the ultimate insider, Salmonella virulence factors that modulate intracellular survival. Cellular Microbiology. 11 (11): 1579-1586. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774479/
7 Lin, Dongxia, Rao, Christopher V., Slauch, James M. The Salmonella SPI1 Type Three Secretion System Responds to Periplasmic Disulfide Bond Status via the Flagellar Apparatus and the RcsCDB System. Journal of Bacteriology. 190(1):87-97. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223759/
8 Oscarsson, Jan et al. Characterization of a pore-forming cytotoxin expressed by Salmonella enterica Serovars Typhi and Paratyphi A. Infection and Immunity. 70(10): 5759-5769. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC128311/
9 Centers for Disease Control and Prevention (CDC). Infectious Diseases Related to Travel – Typhoid and Paratyphoid Fever. Available at http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/typhoid-and-paratyphoid-fever.
10 White, Nicholas J.: Salmonella typhi and S. paratyphi. Antimicrobe 2010.
11 Government of Western Australia Department of Public Health. Typhoid and Paratyphoid fact sheet. Available at http://www.public.health.wa.gov.au/2/601/2/typhoid_and_paratyphoid_fact_sheet.pm#C, 2014.
12 Pakkanen SH, Kantele JM, Kantele A: Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine 2012, 30: 6047-6053.
13 CDC. Traveler’s Health: Typhoid and Paratyphoid Fever. Available at http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/typhoid-and-paratyphoid-fever
14 Maskey AP, et al: Salmonella enterica Serovar Paratyphi A and S. enterica Serovar Typhi Cause Indistinguishable Clinical Syndromes
in Kathmandu, Nepal. Clinical Infectious Diseases 2006, 42: 1247-53.
15 Rezwanul W, et al: Live Oral Typhoid Vaccine Ty21a Induces Cross-Reactive Humoral Immune Responses against Salmonella enterica Serovar Paratyphi A and S. Paratyphi B in Humans. Clinical and Vaccine Immunology 2012, 19(6): 825-834.
16 Baker, S, Karkey, A, Parry, C. Are we adequately prepared for the emergence of Salmonella enterica serovar Paratyphi A?. The Lancet Global Health. http://dx.doi.org/10.1016/S2214-109X(14)70009-9.
17 Elhadad, D., et al. Flagellin is required for host cell invasion and normal SPI-1 expression by Salmonella Paratyphi A. Infection and Immunity. 10.1128/IAI.00468-15. http://www.ncbi.nlm.nih.gov/pubmed/26056383.
18 Teh, C, Chua, K, Thong, K. Paratyphoid Fever: Splicing the Global Analyses. Int J Med Sci. 10.7150/ijms.7768. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045793/.
19 Gal-Mor O, et al: Molecular and Cellular Characterization of a Salmonella enterica Serovar Paratyphi A Outbreak Strain and the Human Immune Response to Infection. Clin Vaccine Immunol. 10.1128/CVI.05468-11. http://cvi.asm.org/content/19/2/146.full.
Created by MaKenzi Burke, Madeline Gabe, Regina Swenton, and Jordan Voth, students of Tyrrell Conway at the University of Oklahoma.
Edited by William Mangin and Tyler Potter, students of Tyrrell Conway at the University of Oklahoma.
